-
EP4200281
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4200281
| EP4200281 - PYRIMIDINONE COMPOUNDS AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 26.05.2023 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 25.02.2022 | Most recent event Tooltip | 27.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Hutchison Medipharma Limited Building 4, 720 Cailun Road Pilot Free Trade Zone Shanghai 201203 / CN | [2023/26] | Inventor(s) | 01 /
SU, Wei-Guo Shanghai 201203 / CN | 02 /
ZHANG, Weihan Shanghai 201203 / CN | 03 /
DENG, Wei Shanghai 201203 / CN | 04 /
YANG, Haibin Shanghai 201203 / CN | [2023/26] | Representative(s) | Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
| Former [2023/26] | Sagittarius IP Marlow International Parkway Marlow, SL7 1YL / GB | Application number, filing date | 21857677.5 | 17.08.2021 | [2023/26] | WO2021CN113038 | Priority number, date | CN202010840261 | 18.08.2020 Original published format: CN202010840261 | CN202110894582 | 05.08.2021 Original published format: CN202110894582 | CN202110928029 | 13.08.2021 Original published format: CN202110928029 | [2023/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022037585 | Date: | 24.02.2022 | Language: | EN | [2022/08] | Type: | A1 Application with search report | No.: | EP4200281 | Date: | 28.06.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.02.2022 takes the place of the publication of the European patent application. | [2023/26] | Search report(s) | International search report - published on: | CN | 24.02.2022 | (Supplementary) European search report - dispatched on: | EP | 22.08.2024 | Classification | IPC: | C07D239/02, C07D403/12, A61K31/505, A61P35/00, A61P37/00, A61P19/02, A61P25/00 | [2023/26] | CPC: |
C07D487/04 (EP,IL,KR,US);
A61K31/513 (EP,IL,KR);
A61K31/519 (EP,IL,KR);
A61K45/06 (EP,IL,US);
A61P19/02 (EP,IL);
A61P25/00 (EP,IL,KR);
A61P29/00 (KR);
A61P35/00 (EP,IL,KR);
A61P37/00 (EP,IL,KR);
C07D239/36 (EP,IL);
C07D239/47 (US);
C07D403/12 (EP,IL,KR,US);
| C-Set: |
A61K31/513, A61K2300/00 (EP);
A61K31/519, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/26] | Title | German: | PYRIMIDINONVERBINDUNGEN UND VERWENDUNGEN DAVON | [2023/26] | English: | PYRIMIDINONE COMPOUNDS AND USES THEREOF | [2023/26] | French: | COMPOSÉS DE PYRIMIDINONE ET LEURS UTILISATIONS | [2023/26] | Entry into regional phase | 24.02.2023 | National basic fee paid | 24.02.2023 | Search fee paid | 24.02.2023 | Designation fee(s) paid | 24.02.2023 | Examination fee paid | Examination procedure | 24.02.2023 | Examination requested [2023/26] | 21.09.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 28.08.2023 | Renewal fee patent year 03 | 27.08.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2019224773 (GLAXOSMITHKLINE IP DEV LTD [GB]) |